Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Kaposi 1Melanoma 1HIV Infections 1Adenoviridae Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Cell Count 2tretazicar 1fludarabine 1enadenotucirev 1Vaccines 1Tumor Necrosis Factor-alpha 1Radiotherapy 1Interferon-beta 1Genetic Engineering 1Endostatins 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenoviridae Infections × Tumor Necrosis Factor-alpha × Clear all
NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed
32 enrolled

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡